The trajectory of copyright's flagship drug presents a complex case for stakeholders in the drug sector. While initially a blockbuster success, generating vast sums, the patent end and the subsequent arrival of https://pharma305437.bloggadores.com/40546927/sildenafil-and-the-pharmaceutical-industry-a-hazardous-bet